Cargando…
Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277098/ https://www.ncbi.nlm.nih.gov/pubmed/35842413 http://dx.doi.org/10.1016/j.jaip.2022.05.035 |
| _version_ | 1784745878542614528 |
|---|---|
| author | Hartono, Stella P. Sharma, Hemant P. Bundy, Vanessa Thompkins, Jessica D. Kochis, Suzanne R. Brooks, Joel P. |
| author_facet | Hartono, Stella P. Sharma, Hemant P. Bundy, Vanessa Thompkins, Jessica D. Kochis, Suzanne R. Brooks, Joel P. |
| author_sort | Hartono, Stella P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9277098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Inc |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92770982022-07-14 Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate Hartono, Stella P. Sharma, Hemant P. Bundy, Vanessa Thompkins, Jessica D. Kochis, Suzanne R. Brooks, Joel P. J Allergy Clin Immunol Pract Clinical Communications Elsevier Inc 2022-08 2022-07-13 /pmc/articles/PMC9277098/ /pubmed/35842413 http://dx.doi.org/10.1016/j.jaip.2022.05.035 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Clinical Communications Hartono, Stella P. Sharma, Hemant P. Bundy, Vanessa Thompkins, Jessica D. Kochis, Suzanne R. Brooks, Joel P. Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title | Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title_full | Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title_fullStr | Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title_full_unstemmed | Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title_short | Safety outcomes of SARS-CoV-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| title_sort | safety outcomes of sars-cov-2 vaccination in pediatric patients with a first dose reaction history or allergy to polyethylene glycol or polysorbate |
| topic | Clinical Communications |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277098/ https://www.ncbi.nlm.nih.gov/pubmed/35842413 http://dx.doi.org/10.1016/j.jaip.2022.05.035 |
| work_keys_str_mv | AT hartonostellap safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate AT sharmahemantp safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate AT bundyvanessa safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate AT thompkinsjessicad safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate AT kochissuzanner safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate AT brooksjoelp safetyoutcomesofsarscov2vaccinationinpediatricpatientswithafirstdosereactionhistoryorallergytopolyethyleneglycolorpolysorbate |